IFPMA Comments as a contribution to the public web-based consultation onthe Draft concept note towards WHO’s 13th General Programme of Work 2019–2023 On behalf of the research-based pharmaceutical industry, the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) welcomes this opportunity to contribute to the World Health Organization’s (WHO) consultation on the Draft concept...
Read moreIFPMA-EFPIA Statement Global call for action on drug-resistant infections, 12-13 October 2017, Berlin Conference organized by Wellcome Trust in partnership with the UK, Ghanaian and Thai governments and the UN Foundation The Innovative Medicines Initiative (IMI) is the world’s biggest public-private partnership in life sciences between the EU (represented by the European Commission) and the...
Read moreAMR Industry Alliance – Statement Global call for action on drug-resistant infections, 12-13 October 2017, Berlin Conference organized by Wellcome Trust in partnership with the UK, Ghanaian and Thai governments and the UN Foundation The AMR Industry Alliance brings together over 100 research-based pharmaceutical, generics, biotech and diagnostic companies and associations, to drive and measure...
Read moreThis blog was first published on Devex on 10 October 2017 Almost 20 years ago, in 1998, 39 leading pharmaceutical companies sued the South African government to stop legislation on parallel imports and generic substitution. It was one of the dumbest things the industry ever did. What started as a technical legal battle became a...
Read moreAgenda item 18: Intergovernmental Committee on Intellectual Property and Genetic Resources, Traditional Knowledge and Folklore (IGC) Delivered by Grega Kumer, IFPMA Head of DG Office & Legal Issues Mr. Chairman, The International Federation of Pharmaceutical Manufactures and Associations would like to take this opportunity to express the position of the research based pharmaceutical industry,...
Read moreThe headlines were about North Korea, warmongering, sanctions and, well, diplomacy. But this year’s UN General Assembly in New York in truth devoted far more time to sustainable development, climate change, mass migration and poverty – and how to provide universal health care (UHC), including for the 400 million who lack access to essential services...
Read moreGENEVA, 13h00 CET – 3 October 2017 – The World Intellectual Property Organization (WIPO) and the research-based pharmaceutical industry today launched a new partnership to promote the accessibility of patent information for health agencies tasked with procurement of medicines. WIPO Director General Francis Gurry and Thomas Cueni, Director General of the International Federation of Pharmaceutical...
Read more